Advancing the Science

Mayo Clinic Medical Science Blog

Share this:
April 30, 2013

Crohn's Disease Activity Index (CDAI) & Patients with Irritable Bowel Syndrome (IBS) – IBD in the News


Edward Loftus Jr., M.D., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses the implications of recent article published in Alimentary Pharmacology & Therapeutics that found a group of patients with IBS to have higher CDAI scores than patients with Crohn’s disease.

Specifically, Dr. Loftus mentions:

- Because signs of Crohn’s disease are neither sensitive nor specific, clinicians can’t rely on symptoms alone to make treatment decisions.

- It is important to support the CDAI score with endoscopic measures, CRP levels, or measure of inflammation in the stool.

For more information on IBD, visit:


Tags: crohn's disease, edward loftus, Findings, gastroenterology, IBD, inflammatory bowel disease, ulcerative colitis


Please login or register to post a comment.
Contact Us · Privacy Policy